15 Wealth Advisors LLC’s AbbVie ABBV Stock Holding History

15 Wealth Advisors LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.37M	Buy	+16,689	New	+$4.28M	1.09%	23

Other funds holding ABBV

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

15 Wealth Advisors LLC's ABBV Position: Q3 2026 in Review

15 Wealth Advisors LLC opened a new position in AbbVie (ABBV) in Q3 2026: 16,689 shares worth $4.37M. The stake represents 1.09% of the portfolio and ranks #23 among its holdings.

541 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

15 Wealth Advisors LLC held 16,689 shares of AbbVie worth $4.37M as of Q3 2026.
AbbVie was a new 15 Wealth Advisors LLC position in Q3 2026.
AbbVie made up 1.09% of 15 Wealth Advisors LLC's portfolio in Q3 2026, its #23 holding.
541 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on 15 Wealth Advisors LLC's 13F filing for Q3 2026, filed 14 Oct 2026.